Queue Ventures Announces TSX Conditional Approval
April 9, 2026
Queue Ventures Ltd. | Access Newswire
Queue Ventures Ltd. has received conditional approval from the Toronto Stock Exchange (TSX) in connection with its proposed business combination with Custom Health — a key step toward becoming a publicly traded company and expanding a scalable, infrastructure-led model for medication management and clinical care.
The transaction remains subject to final TSX approval and customary closing conditions.
This update includes forward-looking statements regarding the proposed transaction and listing. Actual results may differ materially.
